The Feasibility and Validity of Home Spirometry for People with Cystic Fibrosis: Is It Comparable to Spirometry in the Clinic?
Children · 25.02.2025 · 12 (3) · 277
DOI: 10.3390/children12030277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Children, online erschienen am 25.02.2025. Verfasst von Athina Sopiadou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonology and CF Unit, Hippokration Hospital of Thessaloniki, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Home spirometry allows people with cystic fibrosis (CF) to monitor their lung function from home. However, there are concerns about its feasibility and validity compared to traditional clinic spirometry. The aim of this study was to evaluate the feasibility and validity of telehealth spirometry for patients with CF living in a regional setting.
Methods
This retrospective study included forty-eight people with cystic fibrosis (pwCF) aged 6–33 years. Participants performed home spirometry using a portable flow sensor spirometer over a one-year period, without supervision. Spirometry readings from portable spirometers were compared with the nearest in-clinic spirometry using the intra-correlation coefficient (ICC) and Bland–Altman plots. Data were collected over a period of one year, with regular intervals of measurements.
Results
In 427 of the 877 (48.6%) attempted sessions, successful spirometry at home was recorded. Although we showed good reliability between at-home and in-clinic measurements using the Bland–Altman plots and intraclass correlation co-efficient (ICC) (values ranged from 0.76 to 0.88), analysis of the 117 pairs of at-home and in-clinic spirometries showed that mean differences of forced expiratory volume in the 1st sec (FEV1) and forced vital capacity (FVC) obtained at home (both in liter and z-score) had, on average, lower values than the corresponding values at the clinic.
Conclusions
Home-based telehealth spirometry is feasible among pwCF and provides advantages, especially for those from remote or secluded areas. However, lower values in FVC and FEV1 obtained through home spirometry should not be used interchangeably with clinic values.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Pulmonology and CF Unit, Hippokration Hospital of Thessaloniki, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Christos Kogias, Ioustini Kalaitzopoulou, Elpis Hatziagorou
Zitieren
APA
Sopiadou, A., Gioulvanidou, M., Kogias, C., Chrysochoou, E. A., Kalaitzopoulou, I., & Hatziagorou, E. (2025). The Feasibility and Validity of Home Spirometry for People with Cystic Fibrosis: Is It Comparable to Spirometry in the Clinic?. Children, 12(3), 277. https://doi.org/10.3390/children12030277
Vancouver
Sopiadou A, Gioulvanidou M, Kogias C, Chrysochoou EA, Kalaitzopoulou I, Hatziagorou E. The Feasibility and Validity of Home Spirometry for People with Cystic Fibrosis: Is It Comparable to Spirometry in the Clinic?. Children. 2025;12(3):277. doi:10.3390/children12030277
BibTeX
@article{Sopiadou2025,
author = {Sopiadou, Athina and Gioulvanidou, Maria and Kogias, Christos and Chrysochoou, Elissavet-Anna and Kalaitzopoulou, Ioustini and Hatziagorou, Elpis},
title = {The Feasibility and Validity of Home Spirometry for People with Cystic Fibrosis: Is It Comparable to Spirometry in the Clinic?},
journal = {Children},
year = {2025},
volume = {12},
number = {3},
pages = {277},
doi = {10.3390/children12030277}
}
EUVIMED